Study on the Efficacy and Safety of MA-BUCY2 Conditioning in High-risk AML Patients Underwent Haplo-HSCT
Status:
Not yet recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
According to the 2022 ELN guidelines patients with high-risk acute myeloid leukemia were
randomly divided into MA-BUCY2 conditioning group and BuCy2 conditioning group，to evaluate
the efficacy and safety of two conditioning regimens in haploidentical hematopoietic stem
cell transplantation.
Phase:
N/A
Details
Lead Sponsor:
First Affiliated Hospital Xi'an Jiaotong University